HEALTHCARE INSIGHTS
HEALTHCARE INSIGHTS
  • Home
  • #Global Trends
  • #Vietnam
  • #M&A
  • #Regulations
  • #Knowledge
    • #Corporate Wellness
    • #Human Resources
    • #Capability Development
    • #Personal Health
  • Newletter
  • Events
    HEALTHCARE INSIGHTS
    HEALTHCARE INSIGHTS
    • Home
    • #Global Trends
    • #Vietnam
    • #M&A
    • #Regulations
    • #Knowledge
      • #Corporate Wellness
      • #Human Resources
      • #Capability Development
      • #Personal Health
    • Newletter
    • Events

    Category: Uncategorized

    4 Reasons Why Changing A Diabetic Diet Is So Difficult

    03/09/2026 Published by Pharma Biz

    Dietary change is a cornerstone of effective diabetes management. Yet for many people, it is far from easy — our... Read more

    Category: Uncategorized
    Tags: #Personal Health

    Every Employee Can Become A “First Responder”

    03/09/2026 Published by Pharma Biz

    Safety is not one person's job — it is everyone's responsibility In any workplace, incidents can happen without warning: a... Read more

    Category: Uncategorized
    Tags: #Corporate Wellness

    Workforce transformation in the AI era: Redesigning processes over role elimination

    03/09/2026 Published by Pharma Biz

    The illusion of efficiency and the cost of premature restructuring Many corporate layoff announcements currently framed around artificial intelligence reflect... Read more

    Category: Uncategorized
    Tags: #Capability Development

    The invisible class ceiling in compensation negotiations and career advancement

    03/09/2026 Published by Pharma Biz

    In conventional corporate compensation models, negotiation is widely celebrated as a meritocratic mechanism: employees articulate their value proposition, leadership conducts... Read more

    Category: Uncategorized
    Tags: #Human Resources

    Immunology M&A & Precision Autoimmunity: Eli Lilly to Acquire Merida Biosciences for Up to $2.88 Billion in Cash – Bolstering Thyroid Autoimmune Pipeline (MER511) to Diversify Beyond Incretin Blockbusters

    03/09/2026 Published by Pharma Biz

    Key Development On August 31, 2026, global pharmaceutical leader Eli Lilly and Company (NYSE: LLY) entered into a definitive acquisition... Read more

    Category: Uncategorized
    Tags: #M&A

    Next-Generation Vaccinology & In Silico mRNA Platforms: GSK Advances Dual-Antigen (HA + NA) mRNA Seasonal Influenza Candidate to Phase 3 Trials – Challenging Moderna Following Superior Immune Responses in Young and Older Adult Cohorts

    03/09/2026 Published by Pharma Biz

    Key Development On September 1, 2026, British biopharmaceutical leader GSK plc (LSE/NYSE: GSK) announced the advancement of its investigational mRNA-based... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Targeted Thoracic Oncology: AstraZeneca and Hutchmed Report Statistically Significant Progression-Free Survival Benefit in Phase 3 Trial Evaluating First-Line Tagrisso® (Osimertinib) Plus Orpathys® (Savolitinib) in EGFRm / MET+ Advanced NSCLC

    03/09/2026 Published by Pharma Biz

    Key Development On September 1, 2026, biopharmaceutical multinational AstraZeneca (LSE: AZN / Nasdaq: AZN) and its partner Hutchmed (China) Limited... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Consumer Health Antitrust Clearance: Australian Competition and Consumer Commission (ACCC) Approves Kimberly-Clark’s $40 Billion Takeover of Kenvue Conditioned on Divestment of Carefree® and Stayfree® Period Care Brands

    03/09/2026 Published by Pharma Biz

    Key Development On September 2, 2026, the Australian Competition and Consumer Commission (ACCC) granted conditional antitrust clearance for the proposed... Read more

    Category: Uncategorized
    Tags: #M&A

    Pediatric Nutrition Litigation & Product Liability Defense: U.S. Federal Bellwether Jury Delivers Complete Defense Verdict for Mead Johnson (Reckitt) Over Enfamil – Rejecting Causation Claims in Preterm Necrotizing Enterocolitis (NEC)

    03/09/2026 Published by Pharma Biz

    Key Development On September 1, 2026, a federal jury in Illinois returned a complete defense verdict in favor of Mead... Read more

    Category: Uncategorized
    Tags: #Global Trends

    Posts pagination

    Previous page Page 1 … Page 24 Page 25 Page 26 … Page 224 Next page

    Facebook

    Map

    Workday: Monday to Friday
    Working hours: 8am to 5pm
    Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

    Please enable JavaScript in your browser to complete this form.
    Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates
    Loading

    Online Members

    Recent Comments

    • GauTruc on New Biotech Startup Secures $125 Million to Advance Pain Medication
    HEALTHCARE INSIGHTS
    All rights reserved